← Open Payments lookup

RAJEEV SHARMA: Open Payments

NPI 1710309950 · HYANNIS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,132 in 50 payments from 11 companies in 2025. Trend: 2023 $944 · 2024 $1,056 · 2025 $1,132

Food & beverage: $1,032Education: $100
CompanyPaymentsAmount
ABBVIE INC.19$239
Janssen Pharmaceuticals, Inc6$184
Otsuka America Pharmaceutical, Inc.5$123
Teva Pharmaceuticals USA, Inc.2$122
Neurocrine BioSciences, Inc.4$107
Lundbeck LLC4$74
Vanda Pharmaceuticals Inc.2$74
Axsome Therapeutics, Inc.2$56
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$54
E.R. Squibb & Sons, L.L.C.2$52

Products named: VRAYLAR, INVEGA SUSTENNA, ABILIFY ASIMTUFII, INGREZZA, Auvelity, CAPLYTA, COBENFY, ARISTADA.

Industry payments across MA — which companies pay providers there.